Avita Medical | Vermögenswerte



Assets Veränderung Datum
Adcock Ingram Holdings ZAR 8.74B 388.13M 2024-12
Celltrion KRW 20.96T 96.41B 2025-03
Clinuvel Pharmaceuticals AUD 231.12M 19.44M 2024-06
Cochlear AUD 2.79B 41M 2024-12
CSL USD 38.45B 425M 2024-12
Cspc Pharmaceutical CNY 44.39B 3.51B 2024-12
Dianthus Therapeutics USD 326.08M 47.93M 2025-06
Divis Laboratories Ltd 169.32B 13.46B 2025-03
Kangmei Pharma CNY 13.64B 69.1M 2025-06
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Laboratorios Farma EUR 869.6M 37.58M 2025-06
Malin Corporation EUR 198.5M 70.1M 2024-12
Mayne Pharma AUD 1.14B 9.47M 2024-06
Medical Developments International AUD 65.33M 6.17M 2024-12
Nanosonics AUD 255.03M 17.69M 2024-12
Neuren Pharmaceuticals AUD 409.71M 181.55M 2024-12
Organigram Holdings CAD 564.62M 85.41M 2025-06
Pacific Edge NZD 37.03M 13.82M 2025-03
Paradigm Biopharmaceuticals AUD 35.36M 7.97M 2024-12
Pharma Mar EUR 348.25M 14.75M 2025-06
Polynovo AUD 108.72M 11.51M 2024-06
PYC Therapeutics AUD 68.23M 23.01M 2024-12
Qiagen NV USD 5.82B 278.39M 2025-06
Ramsay Health Care AUD 20.66B 237M 2024-12
ResMed USD 8.17B 1.03B 2025-06
Sartorius EUR 10.03B 85.1M 2025-06
Sino Biopharmaceutical CNY 65.41B 1.3B 2024-12
Telix Pharmaceuticals AUD 1.52B 770.47M 2024-12
Tilray USD 4.19B 70.11M 2024-11
Zz Pientze Pharmaceu 18.71B 224.21M 2025-06


Avita Medical Vermögenswerte - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.